Maximal Hyperemia in the Assessment of Fractional Flow Reserve Intracoronary Adenosine Versus Intracoronary Sodium Nitroprusside Versus Intravenous Adenosine: The NASCI (Nitroprussiato Versus Adenosina nelle Stenosi Coronariche Intermedie) Study

Objectives This study sought to compare increasing doses of intracoronary (IC) adenosine or IC sodium nitroprusside versus intravenous (IV) adenosine for fractional flow reserve (FFR) assessment. Background Maximal hyperemia is the critical prerequisite for FFR assessment. Despite IV adenosine currently representing the recommended approach, IC administration of adenosine or other coronary vasodilators constitutes a valuable alternative in everyday practice. However, it is surprisingly unclear which IC strategy allows the achievement of FFR values comparable to IV adenosine. Methods Fifty intermediate coronary stenoses (n = 45) undergoing FFR measurement were prospectively and consecutively enrolled. Hyperemia was sequentially induced by incremental boli of IC adenosine (ADN) (60 mu g ADN60, 300 mu g ADN300, 600 mu g ADN600), by IC sodium nitroprusside (NTP) (0.6 mu g/kg bolus) and by IV adenosine infusion (IVADN) (140 mu g/kg/min). FFR values, symptoms, and development of atrioventricular block were recorded. Results Incremental doses of IC adenosine and NTP were well tolerated and associated with fewer symptoms than IVADN. Intracoronary adenosine doses (0.881 +/- 0.067, 0.871 +/- 0.068, and 0.868 +/- 0.070 with ADN60, ADN300, and ADN600, respectively) and NTP (0.892 +/- 0.072) induced a significant decrease of FFR compared with baseline levels (p < 0.001). Notably, ADN600 only was associated with FFR values similar to IVADN (0.867 +/- 0.072, p = 0.28). Among the 10 patients with FFR values <= 0.80 with IVADN, 5 were correctly identified also by ADN60, 6 by ADN300, 7 by ADN600, and 6 by NTP. Conclusions Intracoronary adenosine, at doses higher than currently suggested, allows obtaining FFR values similar to IV adenosine. Intravenous adenosine, which remains the gold standard, might thus be reserved for those lesions with equivocal FFR values after high (up to 600 mu g) IC adenosine doses. (J Am Coll Cardiol Intv 2012; 5: 402-8) (C) 2012 by the American College of Cardiology Foundation